Thomas C. Chalmers

Thomas C. Chalmers's AcademicInfluence.com Rankings

Thomas C. Chalmers

Philosophy

#3543

World Rank

#5703

Historical Rank

#1118

USA Rank

Logic

#1281

World Rank

#1990

Historical Rank

#391

USA Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Thomas C. Chalmers Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Thomas Clark Chalmers, MD, FACP was famous for his role in the development of the randomized controlled trial and meta-analysis in medical research. Chalmers began his higher education as an English major at Yale College. He obtained his medical degree from Columbia University College of Physicians and Surgeons in 1943. He spent one year as an intern at the NewYork-Presbyterian Hospital, and completed his residency at the Boston City Hospital.

(See a Problem?)

Thomas C. Chalmers's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration (1994) (2014)
The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. (1978) (1578)
A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. (1992) (1447)
A method for assessing the quality of a randomized control trial. (1981) (1411)
Meta-analyses of randomized controlled trials. (1987) (1225)
Cumulative meta-analysis of therapeutic trials for myocardial infarction. (1992) (1130)
Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide (1960) (1034)
The Comparative Effects of Postoperative Analgesic Therapies on Pulmonary Outcome: Cumulative Meta-Analyses of Randomized, Controlled Trials (1998) (1022)
Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. (1990) (907)
Measuring the quality of medical care. A clinical method. (1976) (852)
Randomized versus historical controls for clinical trials. (1982) (791)
Bias in treatment assignment in controlled clinical trials. (1983) (696)
The Comparative Effects of Postoperative Analgesic Therapies on Pulmonary Outcome (1998) (677)
Publication bias and clinical trials. (1987) (645)
Neurolytic Celiac Plexus Block for Treatment of Cancer Pain: A Meta-Analysis (1995) (519)
Chlorination, chlorination by-products, and cancer: a meta-analysis. (1992) (496)
Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes (1993) (454)
Vitamin A supplementation and child mortality. A meta-analysis. (1993) (438)
Renal failure in the patient with cirrhosis. The role of active vasoconstriction. (1970) (413)
A comparison of statistical methods for combining event rates from clinical trials. (1989) (410)
Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. (1977) (393)
Postoperative patient-controlled analgesia: meta-analyses of initial randomized control trials. (1993) (385)
Association of adrenocorticosteroid therapy and peptic-ulcer disease. (1983) (383)
Adjuvant therapy of colorectal cancer. Why we still don't know. (1988) (376)
Getting to grips with Archie Cochrane's agenda. (1992) (374)
Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. (1995) (352)
A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls. (1981) (350)
A meta-analysis of alcohol consumption in relation to risk of breast cancer. (1988) (349)
Large trials vs meta-analysis of smaller trials: how do their results compare? (1996) (343)
A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. (1994) (328)
Endoscopic hemostasis. An effective therapy for bleeding peptic ulcers. (1990) (317)
An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials. (1990) (264)
Functional electrostimulation in poststroke rehabilitation: a meta-analysis of the randomized controlled trials. (1996) (254)
Ascorbic acid for the common cold. A prophylactic and therapeutic trial. (1975) (249)
Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. (1989) (242)
A controlled study of the therapeutic portacaval shunt. (1974) (239)
Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials. (1987) (231)
Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. (1995) (224)
Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis. (1994) (219)
Minimizing the three stages of publication bias. (1990) (213)
A controlled study of the prophylactic portacaval shunt. A final report. (1969) (211)
The Natural History of Cirrhosis (1963) (197)
A quality assessment of randomized control trials of primary treatment of breast cancer. (1986) (195)
The plasma amino acids in patients with liver failure. (1957) (190)
Economic Analysis in Randomized Control Trials (1992) (188)
Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis. (1993) (165)
Perusing the literature: comparison of MEDLINE searching with a perinatal trials database. (1985) (162)
A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel. (1973) (146)
The treatment of acute infectious hepatitis. Controlled studies of the effects of diet, rest, and physical reconditioning on the acute course of the disease and on the incidence of relapses and residual abnormalities. (1955) (145)
Clinical Outcomes and Costs of Transcatheter as Compared with Surgical Closure of Patent Ductus Arteriosus (1993) (143)
Problems induced by meta-analyses. (1991) (143)
Effects of ascorbic acid on the common cold. An evaluation of the evidence. (1975) (143)
Drug Treatment of Hypertension in the Elderly (1994) (137)
The poor quality of early evaluations of magnetic resonance imaging. (1988) (133)
Randomization of the first patient. (1975) (131)
Meta-analysis of clinical trials as a scientific discipline. II: Replicate variability and comparison of studies that agree and disagree. (1987) (130)
A meta-analysis of alcoholic beverage consumption in relation to risk of colorectal cancer (1990) (129)
Antipsychotic drugs: is more worse? a meta-analysis of the published randomized control trials (1994) (123)
Measuring the quality of medical care: second revision of tables of indexes. (1980) (121)
Drug treatment of hypertension in the elderly: a meta-analysis. (1994) (114)
The present status of shunts for portal hypertension in cirrhosis. (1966) (112)
Meta-analysis of empirical long-term antiarrhythmic therapy after myocardial infarction. (1989) (106)
Fulminant hepatic failure. Presumable contribution to halothane. (1969) (105)
Quality assessment of randomized control trials in dental research. I. Methods. (1986) (102)
Absorption of orally administered neomycin and kanamycin with special reference to patients with severe hepatic and renal disease. (1960) (96)
A meta‐analysis of randomized control trials of progestational agents in pregnancy (1989) (96)
Reporting of age data in clinical trials of arthritis. Deficiencies and solutions. (1993) (89)
The transaminase tests in liver disease. (1967) (89)
A controlled trial of colon bypass in chronic hepatic encephalopathy. (1968) (89)
Comparative Efficacy of Epidural, Subarachnoid, and Intracerebroventricular Opioids in Patients With Pain Due to Cancer (1996) (88)
Health-care workers positive for hepatitis B surface antigen. Are their contacts at risk? (1975) (88)
Meta‐Analysis of Randomized Controlled Trials of Cranial Electrostimulation: Efficacy in Treating Selected Psychological and Physiological Conditions (1995) (82)
Exchange transfusion in the treatment of fulminating hepatitis. (1966) (81)
Sensitivity and specificity of clinical trials. Randomized v historical controls. (1983) (80)
RISK OF POST-TRANSFUSION VIRAL HEPATITIS. (1964) (77)
Medium and long chain fat absorption in patients with cirrhosis. (1966) (76)
Antiplatelet agents in the secondary prevention of stroke: meta-analysis of the randomized control trials. (1988) (75)
A meta-analysis of randomized control trials of progestational agents in pregnancy. (1989) (74)
Biofeedback therapy in poststroke rehabilitation: a meta-analysis of the randomized controlled trials. (1995) (73)
Deficiencies of clinical trials of alcohol withdrawal. (1983) (69)
RENAL EFFECTS OF ACUTE EXPANSION OF PLASMA VOLUME IN CIRRHOSIS. (1965) (67)
Omeprazole plus antibiotics in the eradication of Helicobacter pylori infection: a meta-regression analysis of randomized, controlled trials. (1999) (66)
Deafness complicating antibiotic therapy of hepatic encephalopathy. (1970) (66)
THE TREATMENT OF ACUTE INFECTIOUS HEPATITIS. TEN-YEAR FOLLOW-UP STUDY OF THE EFFECTS OF DIET AND REST. (1963) (65)
A Survey of Current Problems in Meta‐Analysis: Discussion from the Agency for Health Care Policy and Research Inter‐PORT Work Group on Literature Review/Meta‐Analysis (1995) (63)
Management of the asymptomatic carrier of the hepatitis-associated (Australia) antigen. Tentative considerations of the clinical and public-health aspects. (1971) (61)
Some Progress and Problems in Meta-Analysis of Clinical Trials (1992) (60)
Pathogenesis and treatment of hepatic failure. (1960) (60)
Viral hepatitis in a group of Boston hospitals. 3. Importance of exposure to shellfish in a nonepidemic period. (1967) (60)
Eastimation of liver size by percussion in normal individuals. (1969) (58)
Quality assessment of randomized control trials in dental research. II. Results: periodontal research. (1986) (58)
Drug surveillance utilizing nurse monitors. An epidemiological approach. (1966) (56)
Randomization and coronary artery surgery. (1972) (56)
Hepatolenticular degeneration (Wilson's disease) as a form of idiopathic cirrhosis. (1957) (56)
A CONTROLLED TRIAL OF PROPHYLACTIC PORTACAVAL-SHUNT SURGERY. (1964) (55)
Physician attitudes toward applications of computer data base systems. (1983) (54)
A meta-analysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease. (1994) (51)
Cost and efficacy of the substitution of ambulatory for inpatient care. (1981) (49)
Variability in absorption of insulin-I 131 in normal and diabetic subjects after subcutaneous and intramuscular injection. (1959) (48)
Fatal gastrointestinal hemorrhage; clinicopathologic correlations in 101 patients. (1952) (47)
The mechanism of copper deposition in the liver in hepatolenticular degeneration (Wilson's disease). (1956) (47)
Ethical Aspects of Clinical Trials (1975) (45)
Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: observations on the role of trial design and implications of drug-related mortality. (1992) (45)
Adjuvant chemotherapy for breast cancer. A pooled estimate based on published randomized control trials. (1986) (43)
The clinical trial. (1981) (42)
The natural history of cirrhosis. I. Survival with esophageal varices. (1963) (40)
Large trials vs meta-analysis of smaller trials. How do their results compare? (1997) (39)
An analysis of the costs of ambulatory and inpatient care. (1986) (38)
Studies of drug usage in five Boston hospitals. (1967) (36)
A CONTROLLED CLINICAL TRIAL OF ASCORBIC ACID FOR THE COMMON COLD (1975) (35)
Cesarean section to reduce perinatal transmission of human immunodeficiency virus. A metaanalysis. (1993) (34)
A Note on Fatality in Serum Hepatitis (1965) (34)
DISTRIBUTION OF AMMONIA ACROSS THE BLOODCEREBROSPINAL FLUID BARRIER IN PATIENTS WITH HEPATIC FAILURE. (1963) (33)
A clinical pharmacologic study of chemotherapy and x-ray therapy in lung cancer. (1967) (33)
ON THE CONCENTRATING DEFECT IN CIRRHOSIS OF THE LIVER. (1964) (33)
Safety of nifedipine in angina pectoris: a meta-analysis. (1999) (33)
STUDIES IN IRON ABSORPTION. III. BODY RADIOACTIVITY MEASUREMENTS OF PATIENTS WITH LIVER DISEASE. (1964) (33)
The Bromsulphalein Test in the Early Diagnosis of Liver Disease in Gross Upper Gastrointestinal Hemorrhage (1950) (32)
Biochemical observations on the use of L-glutamic acid in the treatment of hepatic coma. (1957) (32)
Intravenous Therapy of Massive Ascites in Patients with Cirrhosis: II. Long term effects on survival and frequency of renal failure (1967) (32)
Sodium transport by human ileum in vitro and its response to cholera enterotoxin. (1967) (32)
Methadone vs. L-alpha-acetylmethadol (LAAM) in the treatment of opiate addiction. A meta-analysis of the randomized, controlled trials. (1997) (31)
Clinical outcomes and costs of transcatheter as compared with surgical closure of patent ductus arteriosus. The Patient Ductus Arteriosus Closure Comparative Study Group. (1993) (31)
Residential proximity to electricity transmission and distribution equipment and risk of childhood leukemia, childhood lymphoma, and childhood nervous system tumors: systematic review, evaluation, and meta-analysis (1994) (31)
Methadone vs. L-alpha-acetylmethadol (LAAM) in the Treatment of Opiate Addiction: A Meta-Analysis of the Randomized, Controlled TriaIs (1997) (31)
Are randomized control trial outcomes influenced by the inclusion of a placebo group?: a systematic review of nonsteroidal antiinflammatory drug trials for arthritis treatment. (1999) (30)
COMPARATIVE TRIAL OF CHEMOTHERAPY AND RADIOTHERAPY IN PATIENTS WITH NON-RESECTABLE CANCER OF THE LUNG. (1963) (27)
Clinical trials of hepatitis B immune globulin. Development of policies and materials for the 1972-1975 studies sponsored by the National Heart and Lung Institute. (1975) (27)
Intravenous Therapy of Massive Ascites in Patients with Cirrhosis (1967) (26)
Early roentgen diagnosis in massive bleeding from the upper gastrointestinal tract. I. Clinical evaluation of safety and reliability of the method in 123 patients. (1952) (26)
The impact of controlled trials on the practice of medicine. (1974) (26)
Dipyridamole in the treatment of angina pectoris: A meta‐analysis (1988) (26)
Studies of the cardiovascular system in the hypotension of liver failure. (1962) (25)
Ten-year results of the randomized control trials of coronary artery bypass graft surgery: tabular data compiled by the collaborative effort of the original trial investigators. Part 1 of 2. (1994) (25)
Changes in clinical trials mandated by the advent of meta-analysis. (1996) (24)
Evaluation of a four-day ACTH test in the differential diagnosis of jaundice. (1956) (23)
Efficacy and safety of different aspirin dosages on vascular diseases in high-risk patients. A metaregression analysis. (1995) (22)
Metaanalysis of the effects of intensive glycemic control on late complications of type I diabetes mellitus. (1993) (21)
Effects of octanoic acid on serum-levels of free fatty acids, insulin, and glucose in patients with cirrhosis and in healthy volunteers. (1967) (21)
Conclusions from a controlled trial of the prophylactic portacaval shunt. (1970) (21)
Using MEDLINE to peruse the literature. (1985) (21)
Safety of nifedipine in patients with hypertension: a meta-analysis. (1997) (21)
The effects of supplementary calories on nitrogen storage at high intakes of protein in patients with chronic liver disease. (1956) (20)
Human leukocyte antigen associations of epidemic Kaposi's sarcoma. (1995) (20)
Meta-analysis in clinical medicine. (1988) (20)
Evaluation of portal circulation in hepatic cirrhosis. A new method using xenon. (1969) (20)
Pathologic and functional changes in the liver following upper abdominal operations (1949) (20)
Examination of the early 'learning curve' for transcatheter closure of patent ductus arteriosus using the Rashkind occluder. PDA Closure Comparative Study Group. (1994) (20)
Should mild hypertension be treated? An attempted meta-analysis of the clinical trials. (1985) (19)
THE PASSAGE OF CEPHALOTHIN INTO AND OUT OF ASCITIC FLUID (1967) (19)
Perusing the literature. Methods of accessing MEDLINE and related databases. (1985) (19)
EFFECTS OF HYPOXIA ON IRON ABSORPTION AND MOBILIZATION IN THE RAT. (1964) (19)
A survey of recent therapeutic measures in cirrhosis of the liver. (1949) (19)
COMBINED DIURETIC AND STEROID THERAPY IN CIRRHOSIS WITH ASCITES * (1960) (18)
Early diagnosis in massive gastrointestinal hemorrhage. (1952) (18)
Should the risk of acquired immunodeficiency syndrome deter hepatitis B vaccination? A decision analysis. (1984) (17)
A potpourri of RCT topics. (1982) (17)
A challenge to clinical investigators. (1969) (17)
Can meta-analysis help uncertainty in surgery for otitis media in children (1991) (17)
Randomized clinical trials in surgery. (1979) (17)
VIRAL HEPATITIS IN A GROUP OF BOSTON HOSPITALS. I. A RETROSPECTIVE STUDY OF 1675 PATIENTS. (1965) (17)
Studies in iron absorption. I. Determination in rats by measurement of total body radioactivity. (1960) (16)
INTERIM EXPERIENCE WITH A CONTROLLED STUDY OF PROPHYLACTIC PORTACAVAL SHUNT. (1965) (16)
Mortality Rate Versus Funeral Rate in Clinical Medicine (1964) (16)
Selection and Evaluation of Empirical Research in Technology Assessment (1989) (16)
A belated randomized control trial. (1990) (16)
THE MECHANISM OF COPPER DEPOSITION IN THE LIVER IN HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE) (1956) (16)
"Measuring the quality of medical care": revision of tables of indexes. (1977) (15)
The Lugano Statements on Controlled Clinical Trials (1987) (15)
Loss of patients in clinical trials that measure long-term survival following myocardial infarction. (1986) (14)
Gender-based mortality follow-up from the Program on the Surgical Control of the Hyperlipidemias (POSCH) and meta-analysis of lipid intervention trials. Women in POSCH and other lipid trials. (1996) (14)
Treatment of acute infectious hepatitis in the Armed Forces; advantages of ad lib. bed rest and early reconditioning. (1955) (14)
Underreporting of Viral Hepatitis (1973) (14)
A survey of current problems in meta-analysis. Discussion from the Agency for Health Care Policy and Research inter-PORT Work Group on Literature Review/Meta-Analysis. (1995) (13)
Treatment of acute hepatitis. (1962) (13)
Diabetic treatment and primary ventricular fibrillation in acute myocardial infarction. (1976) (13)
Meta-analysis of branched-chain amino acids in hepatic encephalopathy. (1989) (13)
Early angiography and angioplasty following thrombolytic therapy of acute myocardial infarction. Metaanalysis of the randomized control trials. (1993) (13)
Emergency surgical treatment of bleeding peptic ulcer: an analysis of the published data on 21,130 patients. (1971) (12)
VIRAL HEPATITIS IN A GROUP OF BOSTON HOSPITALS. II. A PROSPECTICE CONTROLLED EPIDEMIOLOGIC STUDY. (1965) (12)
Controls in journal articles. (1979) (11)
Human growth hormone and albumin metabolism in patients with cirrhosis. (1963) (11)
The Rational Use of Therapeutic Drugs in the 21st Century: Important Lessons from Cumulative Meta-analyses of Randomized Control Trials (1995) (11)
The inadequate evidence for short hospital stay after hernia or varicose vein stripping surgery. (1982) (11)
STUDIES IN IRON ABSORPTION. IV. ABSORPTION IN THE PROXIMAL SMALL INTESTINE IN PATIENTS WITH CIRRHOSIS. (1964) (10)
Studies of protein metabolism in hepatolenticular degeneration. (1957) (10)
Prophylactic treatment of Wilson's disease. (1968) (10)
Metabolic studies on the effects of sprinolacton. (1963) (10)
Fat content of very low-calorie diets and gallstone formation. (1992) (9)
Summary of a workshop on the role of third-party payers in clinical trials of new agents. (1983) (9)
Ten-year results of the randomized control trials of coronary artery bypass graft surgery: tabular data compiled by the collaborative effort of the original trial investigators. Part 2 of 2. (1994) (9)
The effects of massive gastrointestinal hemorrhage on hemostasis. I. The blood platelets. (1954) (9)
58A Measuring the impact of the control rate in meta-analysis of clinical trials (1995) (8)
Hepatic coma; clinical and laboratory observations on 40 patients. (1948) (7)
THE OCCURRENCE OF JAUNDICE IN THERAPEUTIC AND NATURAL MALARIA. (1947) (7)
Historical versus randomized controls for clinical trials (1980) (7)
Perusing the literature. (1984) (7)
Neglect of aged in clinical trials (1989) (7)
Drug combinations‐uses, dangers, and fallacies (1964) (6)
Sodium transport inhibition by cholera toxin: the role of non-ionic diffusion of ammonia. (1968) (6)
The management of hepatic coma: A continuing problem. (1968) (6)
Meta-analysis of randomized control trials applied to cancer therapy. (1992) (6)
Meta analysis of randomized control trials of routine antiarrhythmic therapy of post acute myocardial infarction patients indicates urgent need for more trials (1986) (6)
A new physician manpower shortage: clinical investigators. (1979) (6)
Evaluation of the peritoneal-button operation for ascites; report of 17 cases. (1950) (6)
Discussion: Combination of Data from Randomized Control Trials (1982) (6)
Using MEDLINE for perusing the literature: software and search interface of interest to the medical professional. (1985) (6)
A clinical trials database as a research tool in medical care (1991) (6)
Cesium‐137/Potassium‐40 Ratios in Firewood Ashes as a Reflection of Worldwide Radioactive Contamination of the Environment (1990) (5)
Viral hepatitis on the threshold of control. (1975) (5)
Portal hypertension, as seen by 17 authorities (1974) (5)
An evaluation of dietary protein in the treatment of liver disease. (1958) (5)
A clinical trials database as a research tool in health care. (1992) (5)
Nitrogen metabolism after portacaval shunts in patients with cirrhosis. I. Effects of the operation upon the blood ammonia concentration. (1958) (5)
XII. Acute Hemorrhage from the Upper Gastrointestinal Tract (1966) (5)
Observer error in biopsy interpretations and outcome in chronic hepatitis. (1982) (5)
Informed consent, clinical research and the practice of medicine. (1983) (5)
Physical activity after retinal detachment surgery. (1985) (5)
WHO WILL FUND CLINICAL TRIALS (1982) (5)
Are uncontrolled clinical studies ever justified? (1980) (4)
More on MEDLINE searches. (1988) (4)
Can efficacy of blinding in randomized control trials (RCTs) be documented by meta-analysis? (1988) (4)
Use of Prophylactic Tinidazole to Avoid the Serious Infections Associated with Total Abdominal Hysterectomy (1995) (4)
THE EFFECT OF KANAMYCIN ON THE MENTAL AND ELECTROENCEPHALOGRAPHIC ABNORMALITIES AND TREMOR IN CIRRHOSIS AND PULMONARY EMPHYSEMA * (1958) (4)
Renal function and fecal flora after colon bypass. (1970) (4)
A Shortage of Reliable Data (1976) (4)
Assessing the Effectiveness of Ambulatory Cardiac Monitoring for Specific Clinical Indications: Introduction (1993) (4)
Dipyridamole in the treatment of angina pectoris: a meta-analysis. (1988) (4)
Frontiers in liver disease (1981) (4)
Type II diabetes: insulin versus oral agents. (1986) (4)
Clinical trial quality needs to be improved to facilitate metaanalyses. (1993) (3)
A controlled double-blind evaluation of hydroflumethiazide and hydrochlorothiazide. (1961) (3)
Subcutaneous-insulin-resistance syndrome. (1987) (3)
Antioxidants and Cardiovascular Disease: Why Do We Still Not Have the Answers? (1995) (3)
Nonevaluable patients in clinical cancer research (1975) (3)
The potential impact of meta-analysis on medical care (1992) (3)
Investigation of therapy of lung carcinoma. (1960) (3)
The treatment of chronic liver disease. (1948) (3)
Meta-analysis of small old studies of phototherapy for neonatal hyperbilirubinamia compared with a large cooperative trial (1988) (3)
Invited remarks (1979) (3)
Rest and exercise in hepatitis. (1969) (3)
Prisoner Blood Donors and Posttransfusion (Icteric) Viral Hepatitis (1967) (3)
The long-term care challenge: rationalizing a continuum of care for chronically impaired elderly. (1980) (3)
Treatment assignment bias in controlled clinical trials (1981) (3)
Trends in Inflammatory Bowel Disease Therapy: A Meta-Analytic Approach (1995) (2)
Survival from Localized Breast Cancer: Variability Across Trials and Registries (1993) (2)
Trends in IBD therapy: a meta-analytic approach (1994) (2)
Quantitation of Hepatic Blood Flow by Xenon-133 Clearance (1973) (2)
Meta-Analysis of the Effect of Intensive Therapy on Nephropathy in Type I Diabetes Mellitus (1994) (2)
The Boston Inter-hospital Liver Group as an experiment in cooperative research. (1969) (2)
Quality assessment and meta-analysis of randomized control trials of ibuprofen (1987) (2)
The plasma amino acids in patients with liver failure. 1957. (1993) (2)
Randomized controlled clinical trial. National Eye Institute workshop for ophthalmologists. Ethical aspects of clinical trials. (1975) (2)
CLINICAL PHARMACOLOGY AS AN ACADEMIC DISCIPLINE. (1964) (2)
The effects of massive gastrointestinal hemorrhage on hemostasis. II. Coagulation factors. (1954) (1)
Peer Review Using a Paired-Comparison Technique (1984) (1)
[Adjuvant chemotherapy of colorectal cancer: what can be learned from meta-analysis?]. (1989) (1)
The challenges of clinical measurement. (1983) (1)
INFECTION AND INFECTION CONTROL (Including Disinfectants) (1975) (1)
Adjuvant Chemotherapy in Colorectal Cancer: Mournful, Hopeful Perpetual Motion Machine Heads to Dim Light at End of Tunnel-Reply (1989) (1)
CARCINOMA OF THE LUNG, INCLUDING SYSTEMIC MANIFESATIONS. (1965) (1)
The incidence, character and course of liver disease in chronic alcoholics as determined by needle biopsy. (1948) (1)
The prevention of post-transfusion hepatitis: a challenge to physicians and blood banks. (1969) (1)
Third-party payers and investigational therapy. (1988) (1)
Diuretic and steroid therapy in liver disease. (1961) (1)
Randomized controlled clinical trials in diseases of the liver. (1976) (1)
Cimetidine and tranexamic acid for upper-gastrointestinal-tract bleeding. (1983) (1)
Pathogenesis and treatment of hepatic failure. (1960) (1)
The Poor Quality of Early Evaluations of MRI-Reply (1988) (1)
Randomized v Historical Control Trials-Reply (1983) (1)
Clinical Estimation of Liver and Spleen Size (1973) (1)
Meta-analysis of radiotherapy for small-cell lung cancer. (1993) (1)
Searching for signals: mortality and cardiovascular events in published randomized control trials of nifedipine in ischemic heart disease and hypertension (1996) (1)
IMPACT OF RANDOMIZED CONTROL TRIALS ON THE TREATMENT OF ALCOHOL WITHDRAWAL (1982) (1)
When should randomization to untreated control groups stop (1992) (1)
Triage of scarce resources: discussion. (1984) (1)
Global fallout distribution in fireplace ashes. (1989) (1)
Handling of patient dropouts in trials measuring long-term survival (1984) (1)
The need for randomized control trials. (1984) (1)
Keynote address: The need for randomized control trials (1984) (1)
The Scientific session of a meeting held on May 1, 1976 [sound recording] (1976) (0)
Cognitive Therapy for Hypertension (1994) (0)
THE CURRENT STATUS OF "VIRAL PARTICLES" IN HEPATITIS AS VIEWED BY ELECTRON MICROSCOPY (1964) (0)
METABOLISM OF IRON IN DISEASES OF THE LIVER. (1943) (0)
Meta analysis of adjuvant chemotherapy in node positive breast cancer (1985) (0)
INFECTION AND INFECTION CONTROL (1968) (0)
Mammography after 30 years. (1993) (0)
AnAnalysis oftheCostsofAmbulatory andInpatient Care (1986) (0)
Randomize the first patient! (1977) (0)
[Minimizing bias in publication of clinical trials]. (1992) (0)
Centimeters, even inches, but no fingers. (1970) (0)
Viral hepatitis and its sequelae (1961) (0)
The Risk of AIDS After Hepatitis Vaccination-Reply (1985) (0)
RECORDS FOLLOW-UP OF ACUTE INFECTIOUS HEPATITIS CASES TREATED DURING 1951-1952. (1962) (0)
51A Applying the “real-time meta-analysis system” to randomized control trials of congestive heart failure (1995) (0)
44A Comparing results from the largest studies with meta-analyses of smaller studies (1994) (0)
Prognostic factors in chronic liver disease. (1971) (0)
Clinical research and teaching in the academic medical center. (1977) (0)
Stress ulcer prophylaxis in critically ill patients: a meta-analysis (1992) (0)
Medical students' attitudes toward the physician's role in the nuclear age. (1988) (0)
Triage: from government to institutions. (1984) (0)
Peer review of manuscripts. (1977) (0)
Viral hepatitis. (1963) (0)
Commentary on meta‐analysis in clinical trials (1988) (0)
Correction: Booting Up The Quantitative Approach to Patient Care (1989) (0)
Management of emergencies. XXI. Acute hemorrhage from the upper gastrointestinal tract. (1966) (0)
EVIDENCE AGAINST INFECTIOUS HEPATITIS AS A CAUSE OF CIRRHOSIS. (1962) (0)
A CONTROLLED TRIAL OF PROPHYLACTIC PORTA-CAVAL SHUNT SURGERY. (AN INTERIM REPORT). (1964) (0)
A Comparison of the Fructose and Ammonia Tolerance Test in Cirrhosis. (1968) (0)
Randomized Control Trials and Meta‐Analyses in Gastroenterology: Major Achievements and Future Potential (1993) (0)
Book ReviewStatistics in Medicine. (1975) (0)
Clinicopathologic conference postnecrotic cirrhosis of the liver. (1956) (0)
[Limitation of the size of the myocardial infarct by using intracoronary streptokinase administration]. (1982) (0)
Observer bias superimposed on observer variability: Results of a wine tasting (1991) (0)
A study of 40 patients who died in liver coma. (1947) (0)
Cumulative Meta-analyses and the Problem of Multiple Drug Effects-Reply (1993) (0)
A comparison of statistical methods of pooling randomized control trials (RCTs): An assessment of 45 + meta-analyses (M-As) (1992) (0)
Authors' reply (2004) (0)
When and how to stop a clinical trial: invited remarks. (1979) (0)
Stability of meta-analysis (M-As) of randomized control trials (RCTs): A retrospective study of 10 published M-As by sequential M-As and the implications for prospective M-As (1991) (0)
Lidocaine prophylaxis and myocardial infarction. (1982) (0)
Meta-analysis of Alcohol and Risk of Breast Cancer-Reply (1989) (0)
Dietotherapy of acute infectious hepatitis (1954) (0)
Abstract Third annual meeting society for clinical trials May 2–5, 1982 Pisttsburgh Hilton, Gateway Center, Pittsburgh, PAStopping rules in randomized control trials (1982) (0)
American Association for the Study of Liver Diseases 52nd annual meeting. November 9-13, 2001. Dallas, Texas, USA. Abstracts. (1959) (0)
Editorial: A shortage of reliable data. (1976) (0)
A year after the NIH consensus statement on eradication of H. pylori in peptic ulcer disease, how best to do it? (1995) (0)

This paper list is powered by the following services:

Other Resources About Thomas C. Chalmers

en.wikipedia.org

What Schools Are Affiliated With Thomas C. Chalmers?

Thomas C. Chalmers is affiliated with the following schools:

Thomas C. Chalmers's Academic­Influence.com Rankings